This study evaluated the beneficial protective effect of cotreatment of curcumin (CUR) and quercetin (QUE) on atrazine (ATZ)‐induced testicular toxicity in rats. ATZ challenge diminished luteinizing hormone, follicular stimulating hormone, testosterone and myeloperoxidase enzyme activity, but these effects were attenuated on co‐treatment with CUR and QUE. Also, co‐treatment of CUR + QUE was better than separate administration of QUE at diminishing malondialdehyde and glutathione and improving tumour necrosis factor‐α concentration, germ cell numbers (spermatogonia, spermatocytes and round spermatids) and epididymal sperm quality. Histologically, smaller sized tubules with degenerated epithelia and few germ cells were seen in the seminiferous tubules of the ATZ group whereas CUR + QUE pretreatment improved the histo‐morphologic features of the tubules compared to the ATZ group and was also better than separate administration of QUE. We conclude that CUR can improve the protective effects of QUE against ATZ‐induced testicular injury by enhancing the levels of reproductive hormones, recovering testicular biochemical parameters and improving the histological features of the testes.
Introduction: Liver disease remains a severe complication in HIV patients despite advances in treatment with anti-retroviral drugs.
The aim of this study was to analyze and report the prevalence and predictors of liver fibrosis in Nigerian HIV-infected adults on antiretroviral therapy and whether levels of TNF-α and CD4 count are associated with liver fibrosis as measured by FIB-4, we also try to explore the level of liver enzymes dysfunction using liver enzyme biomarkers, Alanine transaminase (ALT), Aspartate transaminase (AST), Alkaline phosphatase (ALP) and categorizing participants using gender (male, female) and age to ascertain if gender and age will be associated with liver fibrosis in Nigerian HIV-infected patients) on Anti-retroviral (ARV) drugs in university of port Harcourt teaching hospital.
Materials and Methods: A hospital-based study was conducted with a sample of 210 patients who were tested using randomized selection. Data on patients’ age and gender were collected, and blood samples were obtained for CD4, TNF, and LFT profiles. Extent of liver fibrosis was determined using the FIB-4, a non-invasive measuring index, to determine the presence and extent of fibrosis by categorizing as follows: FIB-4 value >3.25 as a proxy for advanced or severe fibrosis, FIB-4 value between 1.45 and 3.25 in which fibrosis status is considered as significant fibrosis; FIB-4 value<1.45 considered as no fibrosis or absence of significant fibrosis, FIB-4=[age×AST (IU/liter)/platelet count (109/liter)×ALT (IU/liter)1/2].
Results: The prevalence of liver fibrosis reported was 21% was a slight male dominance in the prevalence ratio. Liver fibrosis correlated negatively with lower CD4 counts and elevated liver function biomarkers and TNF-alpha.
Conclusion: The prevalence of liver fibrosis is high from this study. Increasing in age with elevated liver function biomarkers, TNF-alpha and reduced CD4 counts can be considered as predictors for liver fibrosis. Males are more likely to be affected than females.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.